Financials
- Market Capitalization 253.27 M
- Employee 75
- Founded 2007
- CEO N/A
- Website www.cartesiantherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG001J19Q25
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.06
Relación precio/flujo de caja
90.42
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3440 | NAGE Niagen Bioscience, Inc. - Common Stock | 3.29 USD | -5.19% | -4.08% | -6.53% | -33.94% | 262.03 M USD | ||
| 3459 | SRZN Surrozen, Inc. - Common Stock | 21.88 USD | -4.08% | -4.87% | -5.65% | +162.98% | 254.03 M USD | ||
| 3494 | ACIU AC Immune SA - Common Stock | 2.41 USD | -1.63% | -4.74% | +1.69% | +17.56% | 245.20 M USD | ||
| 3509 | FULC Fulcrum Therapeutics, Inc. - Common Stock | 3.59 USD | +1.41% | -4.27% | +1.70% | -54.44% | 239.21 M USD |